Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects

Nanotechnology in Multiple Myeloma with Dr. Samuel Achilefu, Dr. Ravi Vij and Dr. Monica Shokeen, Washington University
Dr. Samuel Achilefu PhD Dr. Ravi Vij, MD Dr. Monica Shokeen, PhD, MBA Washigton University Interview Date: May 6, 2016
Nanotechnology is the study of very small things, down to the atom and molecule level. Based on the award-winning expertise of Dr. Samuel Achilefu and other experts, the Center for Multiple Myeloma Nanotechnology has now opened at Washington University in St. Louis and is considered a Center of Cancer Nanotechnology Excellence (CCNE).This group is one of six centers to receive a prestigious NIH grant to study nanotechnology in cancer and is the only center to study it in multiple myeloma. In this show, the doctors share that nanotechnology can be used to deliver existing or new drugs in a more targeted and more concentrated way, that it can also be paired with an imaging contrast agent to "light up" the cancer cells and target exactly where the treatment should go, and that it can kick out hiding myeloma cells into the blood so that it can be found and killed. This is a fascinating show that explores an exciting and completely new potential treatment for multiple myeloma. 
Dr. Samuel Achilefu PhD Dr. Ravi Vij, MD Dr. Monica Shokeen, PhD, MBA Washigton University Interview Date: May 6, 2016
Nanotechnology is the study of very small things, down to the atom and molecule level. Based on the award-winning expertise of Dr. Samuel Achilefu and other experts, the Center for Multiple Myeloma Nanotechnology has now opened at Washington University in St. Louis and is considered a Center of Cancer Nanotechnology Excellence (CCNE).This group is one of six centers to receive a prestigious NIH grant to study nanotechnology in cancer and is the only center to study it in multiple myeloma. In this show, the doctors share that nanotechnology can be used to deliver existing or new drugs in a more targeted and more concentrated way, that it can also be paired with an imaging contrast agent to "light up" the cancer cells and target exactly where the treatment should go, and that it can kick out hiding myeloma cells into the blood so that it can be found and killed. This is a fascinating show that explores an exciting and completely new potential treatment for multiple myeloma. 

Ravi Vij, MD, MBA

Jennifer Ahlstrom